

Latest news
Here you can find news items and blogs by Pancreatic Cancer UK staff and guest writers


Our fight for change
In this ever-changing political landscape, we’re determined to make sure that the voice of people affected by pancreatic cancer isn’t forgotten.


The Friday Boys cycle 45 miles for Pancreatic Cancer UK
On 29 July, an inspiring group of friends coined the Friday Boys will cycle 45 miles to raise vital funds for Pancreatic Cancer UK.


New hope for treating pancreatic cancer: Targeting the ‘recycler’ protein USP25
An innovative new study may revolutionise pancreatic cancer therapy by targeting the ‘recycler’ protein USP25 to reduce the growth of cancer cells.


Our response to “gremlin therapy” research that suggests pancreatic cancer can be reversed
New research from the Institute of Cancer Research suggests that it could be possible to reverse a key process that enables pancreatic cancer cells to grow and spread in the body.


Jenny’s call for early diagnosis
This month, we launched our Unite, Diagnose, Save Lives campaign to fight for the breakthrough in early diagnosis that will save lives.


Our Research Involvement Network: Shaping the future of pancreatic cancer research
Dr Naureen Starling is a Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust specialising in the treatment of gastrointestinal cancers, as well as researching new therapies.


A pancreatic cancer podcast discussion
Charles Czajkowski shares his personal experience of pancreatic cancer and talks to Jon Baston-Pitt and Head of Research Dr. Chris Macdonald to discuss the importance of early diagnosis and the issues that our healthcare system faces.


Stand with Mihika to fight for early diagnosis
You may recognise Mihika as one of the faces of our Unite, Diagnose, Save Lives campaign that launched last week. Like so many of our loved ones, Mihika’s husband Jay heard these devastating words when he was finally diagnosed; “Sorry it’s too late. We can’t save you.”


Pancreatic Cancer UK’s partnership with Aviva and Friends wins a Third Sector Award
The team won the award for ‘Challenge Event of the Year’ - where they won recognition for their brave and inspiring fundraising in memory of two former team mates who sadly died of pancreatic cancer.


How we’re influencing cancer strategies across the UK


Only a third of GPs have sufficient access to vital scans needed to diagnose pancreatic cancer
Only 30% of GPs have sufficient access ‘all of the time’ to vital scans needed to diagnose the deadliest common cancer - according to our latest poll.


Our response to the mRNA pancreatic cancer vaccine trial
Our Head of Research, Dr Chris MacDonald comments on the exciting trial results presented at the American Society of Clinical Oncology conference in Chicago.